Clinical

It is imperative that we gather more mature data on a much larger number of patients to accurately assess efficacy, safety, potential harms, durability of response, and impact on disease progression and overall survival of the new immunotherapy treatments.

A study among terminal cancer patients in Japan found that those with a prognosis of days or weeks survived longer when cared for at home.

Individuals with Medicare Advantage plans have lower hospitalization rates than those with traditional fee-for-service Medicare plans.

A retrospective research study has identified disparity in the use of the test, primarily driven by race, insurance status, and the type of facility where treatment was administered.

What we're reading, March 24, 2016: Valeant doubles the price of aid-in-dying drug; the Supreme Court seems split on contraception case; and less than 3% of Americans meet qualifications for a healthy lifestyle.

A new study from the Fred Hutchinson Cancer Research Center has found that boys who underwent chemotherapy to treat their cancer were less likely to father children.

With an increasing population of head and neck cancer survivors in the United States, the American Cancer Society identified the need to develop survivorship guidelines that can lend support to primary care clinicians and other health practitioners as they care for survivors.

Chemotherapy-induced neutropenia is a common adverse effect in children with cancer, yet there are less serious causes of febrile neutropenia for which extended in-hospital treatment might be unnecessary.

Smartphone personal voice assistants, such as Siri and Cortana, often fail to provide appropriate information when asked questions about mental health, rape, and domestic violence.

"Our analysis suggests that annual screens may not be warranted for patients who have had an initial negative scan, and future risk prediction and cost-effectiveness models could incorporate these data to improve screening guidelines," said the study's lead author.

A new study in JAMA Internal medicine has found that the concurrent use of interacting medications has increased since 2005 and that 15% of older adults are potentially at risk for a major drug-drug interaction.

US hospitals continue to have high healthcare-associated infection rates according to a joint report by the Leapfrog Group and Castlight Health.